Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 2
1953 1
1954 1
1956 1
1959 1
1963 3
1964 2
1965 2
1969 2
1971 4
1972 2
1973 5
1974 5
1975 13
1976 10
1977 10
1978 13
1979 17
1980 25
1981 29
1982 27
1983 30
1984 39
1985 71
1986 76
1987 87
1988 106
1989 139
1990 137
1991 186
1992 158
1993 187
1994 217
1995 239
1996 258
1997 245
1998 279
1999 268
2000 341
2001 399
2002 429
2003 597
2004 711
2005 861
2006 1037
2007 1061
2008 1224
2009 1407
2010 1576
2011 1686
2012 2012
2013 2324
2014 2652
2015 3223
2016 3836
2017 3942
2018 4471
2019 4833
2020 4887
2021 5517
2022 6142
2023 5753
2024 2388

Text availability

Article attribute

Article type

Publication date

Search Results

58,844 results

Results by year

Filters applied: . Clear all
Page 1
Hepatitis B vaccination in patients with psoriasis.
Edem W, Banihani S, Martin A, Wu JJ. Edem W, et al. J Am Acad Dermatol. 2023 Oct;89(4):851-853. doi: 10.1016/j.jaad.2023.06.023. Epub 2023 Jun 19. J Am Acad Dermatol. 2023. PMID: 37343831 No abstract available.
Reply.
Wu Y, Shen C, Chen X. Wu Y, et al. Clin Gastroenterol Hepatol. 2019 Nov;17(12):2621-2622. doi: 10.1016/j.cgh.2019.05.015. Clin Gastroenterol Hepatol. 2019. PMID: 31653317 No abstract available.
Retraction of: Use of Decellularized Scaffolds Combined with Hyaluronic Acid and Basic Fibroblast Growth Factor for Skin Tissue Engineering by Wu A, Fan L, Xu B, Lin Y, Zhang P, and Wei X. Tissue Eng 2015;21(1-2):390-402. DOI: 10.1089/ten.tea.2013.0260.
[No authors listed] [No authors listed] Tissue Eng Part A. 2021 May;27(9-10):645. doi: 10.1089/ten.tea.2013.0260.retract. Epub 2020 Mar 19. Tissue Eng Part A. 2021. PMID: 32191567 Free PMC article. No abstract available.
Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
Wu SY, Lan SH, Liu HS. Wu SY, et al. World J Gastroenterol. 2016 Jan 7;22(1):176-87. doi: 10.3748/wjg.v22.i1.176. World J Gastroenterol. 2016. PMID: 26755869 Free PMC article. Review.
Approximately 350 million people worldwide are chronically infected by hepatitis B virus (HBV). HBV causes severe liver diseases including cirrhosis and hepatocellular carcinoma (HCC). ...
Approximately 350 million people worldwide are chronically infected by hepatitis B virus (HBV). HBV causes severe liver diseases incl …
Pathology in Practice.
Wu TK, Kirejczyk SGM, Howerth EW. Wu TK, et al. J Am Vet Med Assoc. 2020 Feb 1;256(3):319-321. doi: 10.2460/javma.256.3.319. J Am Vet Med Assoc. 2020. PMID: 31961272 Free article. No abstract available.
Naturally derived anti-hepatitis B virus agents and their mechanism of action.
Wu YH. Wu YH. World J Gastroenterol. 2016 Jan 7;22(1):188-204. doi: 10.3748/wjg.v22.i1.188. World J Gastroenterol. 2016. PMID: 26755870 Free PMC article. Review.
Despite that some approved drugs and genetically engineered vaccines against hepatitis B virus (HBV) are available for HBV patients, HBV infection is still a severe public health problem in the world. All the approved therapeutic drugs (including interferon-alpha and nucle …
Despite that some approved drugs and genetically engineered vaccines against hepatitis B virus (HBV) are available for HBV patients, …
58,844 results
You have reached the last available page of results. Please see the User Guide for more information.